vs
Intercure Ltd.（INCR）与REGIS CORP（RGS）财务数据对比。点击上方公司名可切换其他公司
REGIS CORP的季度营收约是Intercure Ltd.的1.6倍（$57.1M vs $35.1M）
Intercure Ltd.是一家生物制药企业，研发、生产和销售针对慢性呼吸、心血管及代谢类健康问题的处方与非处方治疗产品，核心市场覆盖北美、欧盟及以色列，服务消费者医疗保健及处方患者群体。
瑞吉斯公司是一家美国美发沙龙运营商，总部位于明尼苏达州明尼阿波利斯市。截至2021年8月，该集团旗下拥有5563家加盟沙龙以及276家直营门店，是北美地区规模领先的美发沙龙连锁经营企业。
INCR vs RGS — 直观对比
营收规模更大
RGS
是对方的1.6倍
$35.1M
损益表 — Q2 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $35.1M | $57.1M |
| 净利润 | — | $456.0K |
| 毛利率 | 29.4% | — |
| 营业利润率 | 4.4% | 10.8% |
| 净利率 | — | 0.8% |
| 营收同比 | — | 22.3% |
| 净利润同比 | — | -94.0% |
| 每股收益（稀释后） | — | $0.16 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收INCRRGS
| Q4 25 | — | $57.1M | ||
| Q3 25 | — | $59.0M | ||
| Q2 25 | $35.1M | $60.4M | ||
| Q1 25 | — | $57.0M | ||
| Q4 24 | — | $46.7M | ||
| Q3 24 | — | $46.1M | ||
| Q2 24 | — | $49.4M | ||
| Q1 24 | — | $49.2M |
净利润INCRRGS
| Q4 25 | — | $456.0K | ||
| Q3 25 | — | $1.4M | ||
| Q2 25 | — | $116.5M | ||
| Q1 25 | — | $250.0K | ||
| Q4 24 | — | $7.6M | ||
| Q3 24 | — | $-853.0K | ||
| Q2 24 | — | $91.2M | ||
| Q1 24 | — | $-2.3M |
毛利率INCRRGS
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 29.4% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
营业利润率INCRRGS
| Q4 25 | — | 10.8% | ||
| Q3 25 | — | 10.0% | ||
| Q2 25 | 4.4% | 12.1% | ||
| Q1 25 | — | 8.8% | ||
| Q4 24 | — | 11.8% | ||
| Q3 24 | — | 4.6% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 8.3% |
净利率INCRRGS
| Q4 25 | — | 0.8% | ||
| Q3 25 | — | 2.3% | ||
| Q2 25 | — | 192.9% | ||
| Q1 25 | — | 0.4% | ||
| Q4 24 | — | 16.4% | ||
| Q3 24 | — | -1.9% | ||
| Q2 24 | — | 184.7% | ||
| Q1 24 | — | -4.7% |
每股收益（稀释后）INCRRGS
| Q4 25 | — | $0.16 | ||
| Q3 25 | — | $0.49 | ||
| Q2 25 | — | $43.67 | ||
| Q1 25 | — | $0.08 | ||
| Q4 24 | — | $2.71 | ||
| Q3 24 | — | $-0.36 | ||
| Q2 24 | — | $38.40 | ||
| Q1 24 | — | $-1.00 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $18.4M |
| 总债务越低越好 | — | $113.3M |
| 股东权益账面价值 | — | $188.7M |
| 总资产 | — | $588.3M |
| 负债/权益比越低杠杆越低 | — | 0.60× |
8季度趋势，按日历期对齐
现金及短期投资INCRRGS
| Q4 25 | — | $18.4M | ||
| Q3 25 | — | $16.6M | ||
| Q2 25 | — | $17.0M | ||
| Q1 25 | — | $13.3M | ||
| Q4 24 | — | $10.2M | ||
| Q3 24 | — | $6.3M | ||
| Q2 24 | — | $10.1M | ||
| Q1 24 | — | $5.9M |
总债务INCRRGS
| Q4 25 | — | $113.3M | ||
| Q3 25 | — | $111.3M | ||
| Q2 25 | — | $110.8M | ||
| Q1 25 | — | $112.0M | ||
| Q4 24 | — | $111.5M | ||
| Q3 24 | — | $95.2M | ||
| Q2 24 | — | $99.5M | ||
| Q1 24 | — | $179.7M |
股东权益INCRRGS
| Q4 25 | — | $188.7M | ||
| Q3 25 | — | $187.6M | ||
| Q2 25 | — | $185.6M | ||
| Q1 25 | — | $68.6M | ||
| Q4 24 | — | $66.7M | ||
| Q3 24 | — | $56.4M | ||
| Q2 24 | — | $56.8M | ||
| Q1 24 | — | $-35.8M |
总资产INCRRGS
| Q4 25 | — | $588.3M | ||
| Q3 25 | — | $592.1M | ||
| Q2 25 | — | $599.0M | ||
| Q1 25 | — | $511.2M | ||
| Q4 24 | — | $530.1M | ||
| Q3 24 | — | $508.9M | ||
| Q2 24 | — | $530.5M | ||
| Q1 24 | — | $543.7M |
负债/权益比INCRRGS
| Q4 25 | — | 0.60× | ||
| Q3 25 | — | 0.59× | ||
| Q2 25 | — | 0.60× | ||
| Q1 25 | — | 1.63× | ||
| Q4 24 | — | 1.67× | ||
| Q3 24 | — | 1.69× | ||
| Q2 24 | — | 1.75× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $1.7M |
| 自由现金流经营现金流 - 资本支出 | — | $891.0K |
| 自由现金流率自由现金流/营收 | — | 1.6% |
| 资本支出强度资本支出/营收 | — | 1.4% |
| 现金转化率经营现金流/净利润 | — | 3.65× |
| 过去12个月自由现金流最近4个季度 | — | $14.9M |
8季度趋势，按日历期对齐
经营现金流INCRRGS
| Q4 25 | — | $1.7M | ||
| Q3 25 | — | $2.3M | ||
| Q2 25 | — | $6.8M | ||
| Q1 25 | — | $6.2M | ||
| Q4 24 | — | $2.1M | ||
| Q3 24 | — | $-1.3M | ||
| Q2 24 | — | $5.1M | ||
| Q1 24 | — | $-277.0K |
自由现金流INCRRGS
| Q4 25 | — | $891.0K | ||
| Q3 25 | — | $1.9M | ||
| Q2 25 | — | $6.2M | ||
| Q1 25 | — | $5.9M | ||
| Q4 24 | — | $1.7M | ||
| Q3 24 | — | $-1.4M | ||
| Q2 24 | — | $5.1M | ||
| Q1 24 | — | $-326.0K |
自由现金流率INCRRGS
| Q4 25 | — | 1.6% | ||
| Q3 25 | — | 3.2% | ||
| Q2 25 | — | 10.3% | ||
| Q1 25 | — | 10.3% | ||
| Q4 24 | — | 3.6% | ||
| Q3 24 | — | -3.0% | ||
| Q2 24 | — | 10.3% | ||
| Q1 24 | — | -0.7% |
资本支出强度INCRRGS
| Q4 25 | — | 1.4% | ||
| Q3 25 | — | 0.7% | ||
| Q2 25 | — | 0.9% | ||
| Q1 25 | — | 0.6% | ||
| Q4 24 | — | 0.9% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | — | 0.1% |
现金转化率INCRRGS
| Q4 25 | — | 3.65× | ||
| Q3 25 | — | 1.68× | ||
| Q2 25 | — | 0.06× | ||
| Q1 25 | — | 24.80× | ||
| Q4 24 | — | 0.28× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.06× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
INCR
暂无分部数据
RGS
| Franchise Segment | $37.9M | 66% |
| Royalty | $13.6M | 24% |
| Other | $2.8M | 5% |
| Fees | $1.8M | 3% |
| Franchise Fees | $1.0M | 2% |
